{"database": "openregs", "table": "documents", "rows": [["FDA-2024-N-5717-0001", "FDA", "FDA-2024-N-5717", "Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments\u2014 Supplemental New Drug Application 218276 S\u2013004 for FABHALTA (iptacopan) Oral Capsules in the Treatment of Adults With C3G", "Notice", "Request for Comments", "2024-12-30T05:00:00Z", 2024, 12, "2024-12-30T05:00:00Z", "2025-02-22T04:59:59Z", "2025-02-22T02:00:45Z", "2024-31309", 0, 0, "09000064868952b7"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2024-N-5717-0001"], "units": {}, "query_ms": 0.4179081879556179, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}